Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aclaris Therapeutics (ACRS) Total Debt: 2017

Historic Total Debt for Aclaris Therapeutics (ACRS) over the last 1 years, with Dec 2017 value amounting to $590,000.

  • Aclaris Therapeutics' Total Debt was N/A to $590,000 in Q4 2017 from the same period last year, while for Dec 2017 it was $590,000, marking a year-over-year change of. This contributed to the annual value of $590,000 for FY2017, which is N/A change from last year.
  • Latest data reveals that Aclaris Therapeutics reported Total Debt of $590,000 as of FY2017.
  • In the past 5 years, Aclaris Therapeutics' Total Debt ranged from a high of $590,000 in FY2017 and a low of $590,000 during FY2017.
  • Over the past 1 years, Aclaris Therapeutics' median Total Debt value was $590,000 (recorded in 2017), while the average stood at $590,000.